Registered number: 13139814

Inclusion Genomics Ltd
Unaudited Financial Statements
for the year ended 31 January 2025

Statement of Financial Position

as at 31 January 2025

  2025
2024
   
££
 
££
Called up share capital not paid  
  -  
 
  -  
Fixed assets  
  -  
 
  -  
Current assets  
32,300    
 
80,934    
Prepayments and accrued income  
-    
 
-    
Creditors: amounts falling due within one year  
( 32,235 )  
 
( 57,114 )  
Net current assets (liabilities)  
  65  
 
  23,820  
Total assets less current liabilities  
  65  
 
  23,820  
Creditors: amounts falling due after more than one year  
  -  
 
  -  
Provisions for liabilities  
  -  
 
  -  
Accruals and deferred income  
  -  
 
  -  
Net assets  
  65  
 
  23,820  
   
Capital and reserves  
  65  
 
  23,820  

xbrli:pure 13139814 2024-02-01 2025-01-31 13139814 2023-02-01 2024-01-31 13139814 2025-01-31 13139814 2024-01-31 13139814 2024-02-01 13139814 uk-frs102:WithinOneYear 2025-01-31 13139814 uk-frs102:AfterOneYear 2025-01-31 13139814 uk-frs102:WithinOneYear 2024-01-31 13139814 uk-frs102:AfterOneYear 2024-01-31 13139814 uk-bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 13139814 uk-bus:FilletedAccounts 2024-02-01 2025-01-31 13139814 uk-bus:Director1 1 2024-02-01 2025-01-31 13139814 uk-bus:Director1 2024-02-01 2025-01-31 13139814 uk-bus:Director1 1 2024-02-01 13139814 uk-bus:Director1 1 2025-01-31 13139814 uk-bus:Micro-entities 2024-02-01 2025-01-31 13139814 uk-bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 iso4217:GBP 13139814 countries:EnglandWales 2024-02-01 2025-01-31 13139814 uk-bus:RegisteredOffice 2024-02-01 2025-01-31

Footnotes to the Statement of Financial Position

Bernardo Alvares

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 1.

3. Directors’ benefits: advances, credit and guarantees

Bernardo Alvares

Included in debtors is an amount payable to the company by one of its directors. The amount is an advance of £20,168 made to Bernardo Alvares, a director of the company, on 01/02/2024.

During the accounting year the maximum amount payable by Bernardo Alvares was £109,486

The following conditions are attached to the amount payable by Bernardo Alvares:

  • There is no interest due to be paid on any outstanding amount
  • No fixed date has been set for the amount to be repaid to the company.
Opening balance 01/02/2024 Additional advance Amount repaid Amount written off Amounts waived Interest payable Closing balance 31/01/2025
£ £ £ £ £ £ £
( 70,771 ) ( 219,686 )
( 219,686 )
270,289
270,289  
0 0 0 ( 20,168 )

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 31/01/2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 13139814

c) The company is a private company and is limited by shares

d) The company's registered office address is 76 May Tree Close, Winchester, Hampshire, SO22 4JF, United Kingdom



Approved by the board of directors and signed on behalf of the board,

Inclusion Genomics Ltd
Director Bernardo Alvares
Date of approval: 09/06/2025
The company was trading for the entire period 2024-02-01 2025-01-31 2025-01-31 Provide strategy consulting services to clients primarily in the pharmaceutical, life sciences, and healthcare sectors. 2025-06-09 2025-06-09